<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37719674</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Interplay between TRIM7 and antiviral immunity.</ArticleTitle><Pagination><StartPage>1256882</StartPage><MedlinePgn>1256882</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1256882</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1256882</ELocationID><Abstract><AbstractText>TRIM7 has been demonstrated to have significant roles in promoting host defense against viral infections and regulating immune signaling pathways. As an E3 ubiquitin ligase, it catalyzes the ubiquitination of various substrates, including adaptor proteins (MAVS and STING) and transcription factors (NF-κB and IRF3), thereby exerting positive or negative regulation on immune signal pathways. However, viruses have developed immune evasion mechanisms to counteract TRIM7. Some viruses can inhibit TRIM7 function by targeting it for degradation or sequestering it away from its targets. Moreover, TRIM7 may even facilitate viral infection by ubiquitinating viral proteins, including envelope proteins that are critical for tissue and species tropism. A comprehensive understanding of the interaction between TRIM7 and antiviral immunity is crucial for the development of innovative treatments for viral diseases.</AbstractText><CopyrightInformation>Copyright © 2023 Liu, Jiang, Sun, Song, Liu and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yiyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University &amp; Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Science and Technology Innovation Center, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Science and Technology Innovation Center, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xuemeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical Science and Technology Innovation Center, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Science and Technology Innovation Center, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yihan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Science and Technology Innovation Center, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Leiliang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University &amp; Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Science and Technology Innovation Center, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="Y">Adaptor Proteins, Signal Transducing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="N">Immune Evasion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="Y">Tripartite Motif Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">E3 ubiquitin ligase</Keyword><Keyword MajorTopicYN="N">MAVS</Keyword><Keyword MajorTopicYN="N">STING</Keyword><Keyword MajorTopicYN="N">TRIM7</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37719674</ArticleId><ArticleId IdType="pmc">PMC10500128</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1256882</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Capece D., Verzella D., Flati I., Arboretto P., Cornice J., Franzoso G. (2022). NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol. 43 (9), 757–775. doi: 10.1016/j.it.2022.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.07.004</ArticleId><ArticleId IdType="pubmed">35965153</ArticleId></ArticleIdList></Reference><Reference><Citation>Carocci M., Bakkali-Kassimi L. (2012). The encephalomyocarditis virus. Virulence 3 (4), 351–367. doi: 10.4161/viru.20573</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.20573</ArticleId><ArticleId IdType="pmc">PMC3478238</ArticleId><ArticleId IdType="pubmed">22722247</ArticleId></ArticleIdList></Reference><Reference><Citation>Carthagena L., Bergamaschi A., Luna J. M., David A., Uchil P. D., Margottin-Goguet F., et al. . (2009). Human TRIM gene expression in response to interferons. PloS One 4 (3), e4894. doi: 10.1371/journal.pone.0004894</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004894</ArticleId><ArticleId IdType="pmc">PMC2654144</ArticleId><ArticleId IdType="pubmed">19290053</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Mar K. B., Sari L., Gaszek I. K., Cheng Q., Evers B. M., et al. . (2021). TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell 184 (13), 3410–3425.e3417. doi: 10.1016/j.cell.2021.04.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.047</ArticleId><ArticleId IdType="pmc">PMC8276836</ArticleId><ArticleId IdType="pubmed">34062120</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., McDougal M. B., Schoggins J. W. (2022). Enterovirus 3C protease cleaves TRIM7 to dampen its antiviral activity. J. Virol. 96 (19), e0133222. doi: 10.1128/jvi.01332-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01332-22</ArticleId><ArticleId IdType="pmc">PMC9555159</ArticleId><ArticleId IdType="pubmed">36106874</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo M. I., Gonzalez-Orozco M., Rajsbaum R. (2023). Pathogenesis of zika virus infection. Annu. Rev. Pathol. 18, 181–203. doi: 10.1146/annurev-pathmechdis-031521-034739</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-031521-034739</ArticleId><ArticleId IdType="pmc">PMC10893765</ArticleId><ArticleId IdType="pubmed">36151059</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo M. I., Xia H., Aguilera-Aguirre L., Hage A., van Tol S., Shan C., et al. . (2020). Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. Nature 585 (7825), 414–419. doi: 10.1038/s41586-020-2457-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2457-8</ArticleId><ArticleId IdType="pmc">PMC7501154</ArticleId><ArticleId IdType="pubmed">32641828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama S. (2017). TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem. Sci. 42 (4), 297–311. doi: 10.1016/j.tibs.2017.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.01.002</ArticleId><ArticleId IdType="pubmed">28118948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopfner K. P., Hornung V. (2020). Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat. Rev. Mol. Cell Biol. 21 (9), 501–521. doi: 10.1038/s41580-020-0244-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0244-x</ArticleId><ArticleId IdType="pubmed">32424334</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Lu Z., Wang X., Liu Y., Han T., Wang Y., et al. . (2020). E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer. Cell Signal 69, 109543. doi: 10.1016/j.cellsig.2020.109543</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109543</ArticleId><ArticleId IdType="pubmed">31958511</ArticleId></ArticleIdList></Reference><Reference><Citation>Koepke L., Gack M. U., Sparrer K. M. (2021). The antiviral activities of TRIM proteins. Curr. Opin. Microbiol. 59, 50–57. doi: 10.1016/j.mib.2020.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7440025</ArticleId><ArticleId IdType="pubmed">32829025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolla S., Ye M., Mark K. G., Rapé M. (2022). Assembly and function of branched ubiquitin chains. Trends Biochem. Sci. 47 (9), 759–771. doi: 10.1016/j.tibs.2022.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2022.04.003</ArticleId><ArticleId IdType="pubmed">35508449</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Yan J., Zhu H., Guo C., Jiang X., Gao Y., et al. . (2023). TRIM7 inhibits encephalomyocarditis virus replication by activating interferon-β signaling pathway. Vet. Microbiol. 281, 109729. doi: 10.1016/j.vetmic.2023.109729</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2023.109729</ArticleId><ArticleId IdType="pubmed">37023504</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X., Xiao J., Li X., Liu Y., Lu Y., Wen Y., et al. . (2022). A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures. Nat. Chem. Biol. 18 (11), 1214–1223. doi: 10.1038/s41589-022-01128-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-022-01128-x</ArticleId><ArticleId IdType="pubmed">35982226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Zhu X., Yang Z., Zhang W., Sun Z., Ji Q., et al. . (2019). E3 ubiquitin ligase tripartite motif 7 positively regulates the TLR4-mediated immune response via its E3 ligase domain in macrophages. Mol. Immunol. 109, 126–133. doi: 10.1016/j.molimm.2019.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2019.01.015</ArticleId><ArticleId IdType="pubmed">30928727</ArticleId></ArticleIdList></Reference><Reference><Citation>Luptak J., Mallery D. L., Jahun A. S., Albecka A., Clift D., Ather O., et al. . (2022). TRIM7 restricts coxsackievirus and norovirus infection by detecting the C-terminal glutamine generated by 3C protease processing. Viruses 14 (8), 1610. doi: 10.3390/v14081610</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081610</ArticleId><ArticleId IdType="pmc">PMC9394474</ArticleId><ArticleId IdType="pubmed">35893676</ArticleId></ArticleIdList></Reference><Reference><Citation>Madiraju C., Novack J. P., Reed J. C., Matsuzawa S. I. (2022). K63 ubiquitination in immune signaling. Trends Immunol. 43 (2), 148–162. doi: 10.1016/j.it.2021.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2021.12.005</ArticleId><ArticleId IdType="pmc">PMC8755460</ArticleId><ArticleId IdType="pubmed">35033428</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfavon-Borja R., Sawyer S. L., Wu L. I., Emerman M., Malik H. S. (2013). An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family. Genome Biol. Evol. 5 (11), 2141–2154. doi: 10.1093/gbe/evt163</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gbe/evt163</ArticleId><ArticleId IdType="pmc">PMC3845644</ArticleId><ArticleId IdType="pubmed">24158625</ArticleId></ArticleIdList></Reference><Reference><Citation>Montori-Grau M., Pedreira-Casahuga R., Boyer-Díaz Z., Lassot I., García-Martínez C., Orozco A., et al. . (2018). GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle. Metabolism 83, 177–187. doi: 10.1016/j.metabol.2018.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2018.02.005</ArticleId><ArticleId IdType="pubmed">29466708</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard R. C., Sullender M. E., Dunlap B. F., Balce D. R., Doench J. G., Virgin H. W. (2019). Identification of antinorovirus genes in human cells using genome-wide CRISPR activation screening. J. Virol. 93 (1), e01324-18. doi: 10.1128/jvi.01324-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01324-18</ArticleId><ArticleId IdType="pmc">PMC6288323</ArticleId><ArticleId IdType="pubmed">30305350</ArticleId></ArticleIdList></Reference><Reference><Citation>Pla-Prats C., Thomä N. H. (2022). Quality control of protein complex assembly by the ubiquitin-proteasome system. Trends Cell Biol. 32 (8), 696–706. doi: 10.1016/j.tcb.2022.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2022.02.005</ArticleId><ArticleId IdType="pubmed">35300891</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C., Dikic I. (2019). Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366 (6467), 818–822. doi: 10.1126/science.aax3769</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax3769</ArticleId><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>Raja R., Sen G. C. (2022). The antiviral action of the RIG-I induced pathway of apoptosis (RIPA) is enhanced by its ability to degrade Otulin, which deubiquitinates IRF3. Cell Death Differ. 29 (3), 504–513. doi: 10.1038/s41418-021-00870-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00870-4</ArticleId><ArticleId IdType="pmc">PMC8901756</ArticleId><ArticleId IdType="pubmed">34545182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Ding T., Zuo Z., Xu Z., Deng J., Wei Z. (2020). Regulation of MAVS expression and signaling function in the antiviral innate immune response. Front. Immunol. 11 1030. doi: 10.3389/fimmu.2020.01030</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01030</ArticleId><ArticleId IdType="pmc">PMC7267026</ArticleId><ArticleId IdType="pubmed">32536927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ru Y., Yan X., Zhang B., Song L., Feng Q., Ye C., et al. . (2022). C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7. Proc. Natl. Acad. Sci. U.S.A. 119 (30), e2203218119. doi: 10.1073/pnas.2203218119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2203218119</ArticleId><ArticleId IdType="pmc">PMC9335266</ArticleId><ArticleId IdType="pubmed">35867826</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Liu Y., Cui Y., Song D., Zhang G., Ma S., et al. . (2020). RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation. PloS Pathog. 16 (3), e1008387. doi: 10.1371/journal.ppat.1008387</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008387</ArticleId><ArticleId IdType="pmc">PMC7069649</ArticleId><ArticleId IdType="pubmed">32126128</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Zhang G., Qin X., Huang Y., Ren X., Sun J., et al. . (2021). Negative regulation of RNF90 on RNA virus-triggered antiviral immune responses targeting MAVS. Front. Immunol. 12. doi: 10.3389/fimmu.2021.730483</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.730483</ArticleId><ArticleId IdType="pmc">PMC8429505</ArticleId><ArticleId IdType="pubmed">34512666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai L., Dietrich A., Skurat A. V., Roach P. J. (2004). Structure-function analysis of GNIP, the glycogenin-interacting protein. Arch. Biochem. Biophys. 421 (2), 236–242. doi: 10.1016/j.abb.2003.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2003.11.017</ArticleId><ArticleId IdType="pubmed">14984203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Liang X., Bao X., Xiao W., Chen G. (2022). Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective. Eur. J. Med. Chem. 235, 114291. doi: 10.1016/j.ejmech.2022.114291</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2022.114291</ArticleId><ArticleId IdType="pubmed">35307617</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>